Business

Dr. Reddy’s Laboratories announces the launch of Redyx in India 43243t

Hyderabad, India, September 9, 2020 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Remdesivir, under a brand […]

Business

Dr. Reddy’s Laboratories enters hospital nutrition segment with Celevida Maxx in India a6369

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY), today announced the entry into the hospital nutrition segment with the launch of its nutrition drink, ‘Celevida Maxx’ in India. It is a unique […]

Health

Dr. Reddy’s Laboratories announces the launch of AVIGAN(R) (Favipiravir) in India 232b4b

Hyderabad, India, August 19, 2020 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of AVIGAN® (Favipiravir) 200 […]